United Therapeutics Builds a Moat Around Lung Transplants

United Therapeutics’ (NASDAQ: UTHR) FDA‑approved lung perfusion platform is an organ‑supply expansion story that supports the company’s broader lung‑transplant and xenotransplantation strategy, rather than a…